BriaCell Therapeutics Corp. (BCTX) Interest Coverage Ratio (2021 - 2026)

BriaCell Therapeutics has reported Interest Coverage Ratio for 6 years, with the latest figure at 257.19 in Q2 2026.

• Quarterly Interest Coverage Ratio fell 50.29% year-over-year to 257.19 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 914.57 (down 189.14% YoY) and the FY2025 annual result came in at 1.12, up 39.5% from the prior year.
• Interest Coverage Ratio climbed to 257.19 in Q2 2026 per BCTX's latest filing, from 15062.53 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 224.46 in Q3 2025 and troughed at 15411.52 in Q3 2023.
• A 5-year average of 2637.71 and a median of 193.56 in 2025 frame the typical range for Interest Coverage Ratio.
• The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio slumped 434.64% in 2022, then soared 108.21% in 2025.
• Over 5 years, Interest Coverage Ratio stood at 51.17 in 2022, then sank by 361.62% to 236.2 in 2023, then surged by 42.76% to 135.21 in 2024, then sank by 43.15% to 193.56 in 2025, then tumbled by 32.88% to 257.19 in 2026.
• According to Business Quant data, Interest Coverage Ratio over the past three periods registered 257.19, 15062.53, and 193.56 for Q2 2026, Q1 2026, and Q4 2025 respectively.